The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Perioperative nivolumab (NIVO) vs placebo (PBO) in patients (pts) with resectable NSCLC: Updated survival and biomarker analyses from CheckMate 77T.
 
Tina Cascone
Honoraria - American Society of Clinical Oncology; AstraZeneca; Bio Ascend; Brystol-Myers Squibb; Clinical Care Options; IDEOlogy Health; Medical Education Consortium; Medscape; Onclive; PEAK Medicals; Peerview; Physicans' Education Resource; Targeted Oncology
Consulting or Advisory Role - AstraZeneca; Bristol Myers Squibb; Daiichi Sankyo; Genentech; Merck; oNKo-innate; Pfizer; RAPT Therapeutics; Summit Therapeutics
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Merck (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bio Ascend; Bristol-Myers Squibb; IDEOlogy Health; Medical Education Consortium; Merck; OncLive/MJH Life Sciences; PEAK Medicals; Peerview
 
Mark Awad
Consulting or Advisory Role - Affini-T Therapeutics; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Coherus Biosciences; EMD Serono; Foundation Medicine; Gritstone Bio; Instil Bio; Janssen; Merck; Mirati Therapeutics; Novartis; Pfizer; Regeneron
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Bristol Myers Squibb Foundation
 
Jonathan Spicer
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb/Medarex; Chemocentryx; Merck; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Medarex; Merck; Protalix Biotherapeutics; Regeneron; Xenetic Biosciences
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb/Medarex (Inst); CLS-Therapeutics (Inst); CLS-Therapeutics (Inst); Merck (Inst); Protalix Biotherapeutics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb/Medarex; Merck
 
Jie He
No Relationships to Disclose
 
Shun Lu
Leadership - Innovent BIOLOGICS, INC; Shanghai Fosun; Simcere Zaiming
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; GenomiCare; Hutchison MediPharma; InventisBio Co. Ltd; Menarini; Pfizer; Roche; Simcere; Yuhan; Zai Lab
Speakers' Bureau - AstraZeneca; Hansoh Pharma; Hengrui Therapeutics; Roche
Research Funding - AstraZeneca (Inst); BeiGene (Inst); BMS (Inst); Hansoh (Inst); Hengrui Therapeutics (Inst); Hutchison MediPharma (Inst); Lilly Suzhou Pharmaceutical Co. (Inst); Roche (Inst)
 
Fumihiro Tanaka
Consulting or Advisory Role - AstraZeneca; Chugai Pharma; Ono Pharmaceutical
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Covidien/Medtronic; Intuitive Japan; Johnson & Johnson/Janssen; Kyowa Kirin International; Lilly Japan; MSD; Olympus Medical Systems; Ono Pharmaceutical; Pfizer; Stryker; Taiho Pharmaceutical; Takeda
Research Funding - Boehringer Ingelheim (Inst); Chugai Pharma (Inst)
 
Robin Cornelissen
Honoraria - Bristol-Myers Squibb/Pfizer; MSD Oncology; Pfizer; Roche
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex; MSD
 
Lubos Petruzelka
No Relationships to Disclose
 
Hiroyuki Ito
No Relationships to Disclose
 
Ludmila Koch
No Relationships to Disclose
 
Lin Wu
No Relationships to Disclose
 
Sabine Bohnet
Consulting or Advisory Role - AstraZeneca; Bristol Myers Squibb Foundation; MSD; Roche
 
Cinthya Coronado Erdmann
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Stephanie Meadows-Shropshire
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Jaclyn Neely
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Amy Hung
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Padma Sathyanarayana
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Sumeena Bhatia
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
(OPTIONAL) Uncompensated Relationships - Bristol-Myers Squibb
 
Mariano Provencio
Honoraria - AstraZeneca; BMS; Janssen; Lilly; MSD; Pfizer; Roche; Roche; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Gilead Sciences; Guardant Health; Incyte; Ipsen; Janssen Oncology; Johnson & Johnson; Lilly; Merck; MSD; Pfizer; Roche; Roche; Takeda
Speakers' Bureau - Amgen; AstraZeneca; BMS; Janssen; Johnson & Johnson/Janssen; Lilly; MSD; Pfizer; Roche; Roche; Takeda
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; BMS; Boehringer Ingelheim; Boehringer Ingelheim; Bristol Myers Squibb Company; Janssen; Lilly; MSD; Pfizer; Pierre Fabre; ROCHE; Roche; Roche; Takeda
Other Relationship - Pfizer